Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Colorectal Surgery

Surgical Options: Preventing Cancer and Preserving Function

At a Glance

Preventive surgery is the most effective way to manage colorectal cancer risk in Familial Adenomatous Polyposis (FAP). The main options are TAC/IRA, which preserves the rectum for better bowel function, and the J-pouch, which removes the rectum for maximum cancer protection.

When managing FAP, surgery is not a failure of treatment; it is the most effective tool we have to prevent cancer. Because the risk of colorectal cancer is nearly certain in Classic FAP, the question is usually not if surgery will happen, but when and which type is best for your specific situation.

When is Surgery Indicated?

  • Classic FAP: Prophylactic (preventive) surgery is typically recommended in the late teens or early 20s [1][2]. Doctors look for “triggers” like a high number of polyps (especially those larger than 5–10 mm), polyps that show advanced abnormal cells (dysplasia), or symptoms like bleeding [3][4].
  • Attenuated FAP (AFAP): Because AFAP involves fewer polyps and a later onset of cancer, surgery may be delayed as long as the polyps can be safely managed and removed during regular colonoscopies [5][6].

Comparing the Two Main Surgical Options

There are two primary ways surgeons address FAP. The choice depends on your age, your genotype, and how many polyps are in your rectum.

1. TAC/IRA (Total Abdominal Colectomy with Ileorectal Anastomosis)

In this procedure, the surgeon removes the colon but leaves the rectum in place, attaching the small intestine directly to it.

  • Pros: It is a less complex surgery with better bowel function and generally higher quality of life [7][8]. For women, it better preserves natural fertility compared to the J-pouch, because it avoids deep pelvic scarring [8].
  • Cons: You still have a rectum, which means you still have FAP tissue. There is a high risk that new polyps will form, and up to 50% of patients eventually need a second surgery to remove the rectum later in life [7][9].
  • Best for: Patients with fewer than 15–20 rectal polyps and no family history of severe rectal disease [7].

2. TPC/IPAA (Total Proctocolectomy with Ileal Pouch-Anal Anastomosis, or “J-Pouch”)

In this procedure, both the colon and the rectum are removed. The surgeon creates a “pouch” out of the end of the small intestine to act as a new rectum.

  • Pros: This offers the highest level of cancer protection because almost all at-risk tissue is removed [10][11].
  • Cons: It is a more complex surgery that often requires two stages and a temporary stoma (a surgically created opening that redirects waste into a bag for a few months while the new internal pouch heals) [10]. It usually results in more frequent bowel movements (typically 4–8 per day). For women, the deep pelvic surgery can cause scarring that affects fertility; younger women are encouraged to consult a fertility specialist prior to surgery. It also carries a higher risk of desmoid tumors [12][10].
  • Best for: Patients with a high rectal polyp burden or mutations (like those in codons 1250–1464) that suggest severe disease is likely [13][14].

The Role of Desmoid Tumors in Surgical Choice

Desmoid tumors are aggressive, non-cancerous growths that can be triggered by surgery. This is a major factor in decision-making:

  • Higher Risk with J-Pouch: The more extensive surgery required for a J-pouch (IPAA) is associated with a significantly higher risk of developing abdominal desmoid tumors compared to the simpler IRA procedure [12].
  • Family History: If you have a family history of desmoids, your team may lean toward the IRA to minimize surgical trauma [12].

A Note on Chemoprevention

You may hear about drugs like sulindac, celecoxib, or eflornithine.

  • What they do: These medications (often NSAIDs) can help shrink existing polyps or slow down the growth of new ones [15][16].
  • What they DON’T do: They are not a replacement for surgery. While they may help delay surgery or manage polyps in a remaining rectum or pouch, they do not eliminate the risk of cancer [15][17]. Surgery remains the gold standard for cancer prevention in FAP.
  • Safety Warning: Long-term use of NSAIDs like sulindac and celecoxib carries significant risks, including cardiovascular issues (like heart attack or stroke) and gastrointestinal bleeding. They must be carefully evaluated and monitored by your doctor.

Common questions in this guide

When should I have preventive surgery for FAP?
For Classic FAP, preventive surgery is typically recommended in the late teens or early twenties, especially if you have many large polyps or signs of advanced abnormal cells. For Attenuated FAP, surgery may be delayed as long as polyps can be safely removed during routine colonoscopies.
What is the difference between an IRA and a J-pouch surgery?
An IRA removes the colon but leaves the rectum in place, offering better bowel function but requiring lifelong screening of the remaining rectal tissue. A J-pouch removes both the colon and rectum, offering higher cancer protection but usually resulting in more frequent bowel movements and a temporary stoma.
Will FAP surgery affect my fertility?
The deeper pelvic surgery required for a J-pouch can cause scarring that may negatively impact female fertility. The IRA procedure generally preserves natural fertility better. It is highly recommended that younger women consult a fertility specialist prior to deciding on a surgical option.
Can medications replace surgery for FAP?
No, medications like sulindac or celecoxib cannot replace surgery. While these drugs can help shrink existing polyps or slow the growth of new ones, they do not eliminate the risk of cancer and are used to manage polyps before or after surgical treatment.
How do desmoid tumors affect my FAP surgery options?
Desmoid tumors are non-cancerous but aggressive growths that can be triggered by surgical trauma. Because the J-pouch procedure is more extensive, it carries a higher risk of triggering these tumors compared to an IRA. This risk is an important factor to discuss with your surgeon.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many polyps were found in my rectum, and are they small enough to consider an IRA?
  2. 2.Based on my specific APC mutation and family history, is my risk of desmoid tumors high enough to favor one surgery over the other?
  3. 3.If I choose the IRA, what is the chance I will eventually need a second surgery to remove the rectum later in life?
  4. 4.What are your typical functional outcomes for J-pouches, and how many bowel movements per day should I expect?
  5. 5.Will this surgery be performed laparoscopically, and how will that affect my recovery and desmoid risk?
  6. 6.How long will I likely be in the hospital after surgery, and when can I expect to return to work?
  7. 7.For female patients: How does each surgical option impact my future fertility, and should I consult a specialist?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Familial adenomatous polyposis: a case study.

    Yorke J, Yamoah FA, Awoonor-Williams R, et al.

    Journal of surgical case reports 2020; (2020(10)):rjaa367 doi:10.1093/jscr/rjaa367.

    PMID: 33133502
  2. 2

    Germline mutations of the adenomatous polyposis coli (APC) gene in Algerian familial adenomatous polyposis cohort: first report.

    Khider F, Cherbal F, Boumehdi AL, et al.

    Molecular biology reports 2022; (49(5)):3823-3837 doi:10.1007/s11033-022-07228-0.

    PMID: 35142982
  3. 3

    Optimizing the timing of colorectal surgery in patients with familial adenomatous polyposis in clinical practice.

    Vasen HFA, Ghorbanoghli Z, de Ruijter B, et al.

    Scandinavian journal of gastroenterology 2019; (54(6)):733-739 doi:10.1080/00365521.2019.1621930.

    PMID: 31401889
  4. 4

    Endoscopic management of familial adenomatous polyposis targeting colorectal lesions greater than 5 mm in size: a single-center retrospective study.

    Murano T, Ikematsu H, Shinmura K, et al.

    Familial cancer 2023; (22(1)):83-89 doi:10.1007/s10689-022-00308-x.

    PMID: 35930210
  5. 5

    Incidental Finding of Attenuated Familial Adenomatous Polyposis.

    Bhesania S, Chelikam N, Mobin N, et al.

    Cureus 2021; (13(9)):e18237 doi:10.7759/cureus.18237.

    PMID: 34722036
  6. 6

    Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.

    Sokic-Milutinovic A

    Digestive diseases (Basel, Switzerland) 2019; (37(5)):400-405 doi:10.1159/000497207.

    PMID: 30836352
  7. 7

    Risk of Proctectomy After Ileorectal Anastomosis in Familial Adenomatous Polyposis in the Modern Era.

    Banerjee S, Burke CA, Sommovilla J, et al.

    Diseases of the colon and rectum 2024; (67(3)):427-434 doi:10.1097/DCR.0000000000003157.

    PMID: 38064246
  8. 8

    A Decision Analysis for Rectal-Sparing Familial Adenomatous Polyposis: Total Colectomy With Ileorectal Anastomosis Versus Proctocolectomy With IPAA.

    Melnitchouk N, Saadat LV, Bleday R, Goldberg JE

    Diseases of the colon and rectum 2019; (62(1)):27-32 doi:10.1097/DCR.0000000000001186.

    PMID: 30394986
  9. 9

    Risk of extracolonic malignancies and metachronous rectal cancer after colectomy and ileorectal anastomosis in familial adenomatous polyposis.

    Sasaki K, Nozawa H, Kawai K, et al.

    Asian journal of surgery 2022; (45(1)):396-400 doi:10.1016/j.asjsur.2021.06.034.

    PMID: 34330586
  10. 10

    Complications Related to J-Pouch Surgery.

    Freeha K, Bo S

    Gastroenterology & hepatology 2018; (14(10)):571-576.

    PMID: 30846911
  11. 11

    Review article: the pathogenesis of pouchitis.

    Schieffer KM, Williams ED, Yochum GS, Koltun WA

    Alimentary pharmacology & therapeutics 2016; (44(8)):817-35 doi:10.1111/apt.13780.

    PMID: 27554912
  12. 12

    Development of Desmoid Tumors After Ileorectal Anastomosis Versus Ileal Pouch-Anal Anastomosis in Familial Adenomatous Polyposis.

    Aelvoet AS, Pellisé M, Miedema TN, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(11)):2319-2326 doi:10.1016/j.cgh.2024.06.018.

    PMID: 38969075
  13. 13

    Attenuated Familial Adenomatous Polyposis: A Phenotypic Diagnosis but Obsolete Term?

    Anele CC, Martin I, McGinty Duggan PM, et al.

    Diseases of the colon and rectum 2022; (65(4)):529-535 doi:10.1097/DCR.0000000000002217.

    PMID: 34775416
  14. 14

    Adenomatous Polyposis Coli Gene Mutations, Risk Factors, and Long-term Outcomes Associated With Desmoid Tumors in Patients With Familial Adenomatous Polyposis After Colectomy in Japan.

    Kojima T, Kurachi K, Iwaizumi M, et al.

    Journal of clinical gastroenterology 2025; (59(7)):583-591 doi:10.1097/MCG.0000000000002071.

    PMID: 39729982
  15. 15

    Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical Trial.

    Balaguer F, Stoffel EM, Burke CA, et al.

    Diseases of the colon and rectum 2022; (65(4)):536-545 doi:10.1097/DCR.0000000000002095.

    PMID: 34261858
  16. 16

    Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.

    Ishikawa H, Mutoh M, Sato Y, et al.

    The lancet. Gastroenterology & hepatology 2021; (6(6)):474-481 doi:10.1016/S2468-1253(21)00018-2.

    PMID: 33812492
  17. 17

    Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis.

    Burke CA, Dekker E, Lynch P, et al.

    The New England journal of medicine 2020; (383(11)):1028-1039 doi:10.1056/NEJMoa1916063.

    PMID: 32905675

This information about surgical options for FAP is for educational purposes only. Always consult a colorectal surgeon to determine the safest surgical approach, timing, and fertility preservation plan for your specific case.

Get notified when new evidence is published on Familial Adenomatous Polyposis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.